Prospective study on the efficacy of a selective treatment and risk factors for relapse in recurrent calcium oxalate stone patients

European Urology

Volumn 44, Issue 4, 2003, Pages 467-474

  Siener, Roswitha ^a   Glatz, Sara ^a   Nicolay, Claudia ^a   Hesse, Albrecht ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Dietary and medical treatment; Recurrent calcium oxalate lithiasis; Risk factors for recurrence

Indexed keywords

ALKALI; ALKALINE CITRATE; ALLOPURINOL; CITRIC ACID; MAGNESIUM; POTASSIUM; THIAZIDE DIURETIC AGENT; UNCLASSIFIED DRUG;

ADULT; ALKALINIZATION; ARTICLE; CALCIUM OXALATE STONE; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; DRINKING; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLISM; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUTRITION; PATIENT COMPLIANCE; POTASSIUM EXCRETION; POTASSIUM URINE LEVEL; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; RECURRENT DISEASE; RELAPSE; RISK FACTOR; URINE PH; URINE VOLUME;

EID: 0141683580     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00317-8     Document Type: Article

References (22)

1. Chandhoke PS. When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol 2002;168:937-40.
2. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996;155:839-43.
3. Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002;346:77-84.
4. Ohkawa M, Tokunaga S, Nakashima T, Orito M, Hisazumi H. Thiazide treatment for calcium urolithiasis in patients with idiopathic hypercalciuria. Br J Urol 1992;69:571-6.
5. Ettinger B, Tang A, Citron JT, Livermore B, Williams T. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986;315:1386-9.
6. Barcelo P, Wuhl O, Servitge E, Rousaud A, Pak CYC. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993;150:1761-4.
7. Tiselius HG, Ackermann D, Alken P, Buck C, Conort P, Gallucci M. Guidelines on urolithiasis. Eur Urol 2001;40:362-71.
8. Hesse A, Tiselius HG, Jahnen A. Urinary stones. Diagnosis, treatment, and prevention of recurrence. 2nd ed. Basel: Karger; 2002.
9. Werness PG, Brown CM, Smith LH, Finlayson B. EQUIL2. A basic computer program for the calculation of urinary saturation. J Urol 1985;134:1242-4.
10. Parks JH, Coe FL. An increasing number of calcium oxalate stone events worsens treatment outcome. Kidney Int 1994;45:1722-30.
11. Carr LK, Honey J, Jewett MA, Ibanez D, Ryan M, Bombardier C. New stone formation: a comparison of extracorporeal shock wave lithotripsy and percutaneous nephrolithotomy. J Urol 1996;155: 1565-7.
12. Streem SB, Yost A, Mascha E. Clinical implications of clinically insignificant stone fragments after extracorporeal shock wave lithotripsy. J Urol 1996;155:1186-90.
13. Consensus Conference. Prevention and treatment of kidney stones. JAMA 1988;260:977-81.
14. Keßler T, Hesse A. Cross-over study of the influence of bicarbonate-rich mineral water on urinary composition in comparison with sodium potassium citrate in healthy male subjects. Brit J Nutr 2000;84:865-71.
15. Siener R, Hesse A. The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects. Eur Urol 2002;42:289-96.
16. Siener R, Ebert D, Nicolay C, Hesse A. Dietary risk factors for hyperoxaluria in calcium oxalate stone formers. Kidney Int 2003; 63:1037-43.
17. Liebman M, Costa G. Effects of calcium and magnesium on urinary oxalate excretion after oxalate loads. J Urol 2000;163:1565-9.
18. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 1993;328:833-8.
19. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med 1997;126:497-504.
20. Strauss AL, Coe FL, Deutsch L, Parks JH. Factors that predict relapse of calcium nephrolithiasis during treatment. Am J Med 1982;72:17-24.
21. Norman RW, Bath SS, Robertson WG, Peacock M. When should patients with symptomatic stone disease be evaluated metabolically? J Urol 1984;132:1137-9.
22. Robertson WG. Medical management of urinary stone disease. European Urology Update Series 1998;7:139-44.